145 related articles for article (PubMed ID: 8875617)
1. Expression of HCV envelope proteins and the serological utility of the anti-E2 immune response.
Lesniewski RR; Watanabe S; Devare SG
Princess Takamatsu Symp; 1995; 25():129-37. PubMed ID: 8875617
[TBL] [Abstract][Full Text] [Related]
2. Processing of E1 and E2 glycoproteins of hepatitis C virus expressed in mammalian and insect cells.
Matsuura Y; Suzuki T; Suzuki R; Sato M; Aizaki H; Saito I; Miyamura T
Virology; 1994 Nov; 205(1):141-50. PubMed ID: 7975209
[TBL] [Abstract][Full Text] [Related]
3. Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV.
León P; López JA; Elola C; Domingo CJ; Echevarria JM
Vox Sang; 1996; 70(4):213-6. PubMed ID: 9123926
[TBL] [Abstract][Full Text] [Related]
4. Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteins.
Satoi J; Murata K; Lechmann M; Manickan E; Zhang Z; Wedemeyer H; Rehermann B; Liang TJ
J Virol; 2001 Dec; 75(24):12121-7. PubMed ID: 11711603
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus infection in dialysis and chronic liver patients: Viraemia dependent anti-E2-antibody response.
Hanuka N; Sikuler E; Tovbin D; Neville L; Nussbaum O; Mostoslavsky M; Orgel M; Yaari A; Manor S; Dagan S; Hilzenrat N; Shemer-Avni Y
J Med Virol; 2004 Aug; 73(4):529-35. PubMed ID: 15221896
[TBL] [Abstract][Full Text] [Related]
6. Characterization of pseudotype VSV possessing HCV envelope proteins.
Matsuura Y; Tani H; Suzuki K; Kimura-Someya T; Suzuki R; Aizaki H; Ishii K; Moriishi K; Robison CS; Whitt MA; Miyamura T
Virology; 2001 Aug; 286(2):263-75. PubMed ID: 11485395
[TBL] [Abstract][Full Text] [Related]
7. Recombinant hepatitis C virus-like particles expressed by baculovirus: utility in cell-binding and antibody detection assays.
Xiang J; Wünschmann S; George SL; Klinzman D; Schmidt WN; LaBrecque DR; Stapleton JT
J Med Virol; 2002 Dec; 68(4):537-43. PubMed ID: 12376962
[TBL] [Abstract][Full Text] [Related]
8. Antibody responses to the hepatitis C virus E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects.
Cerino A; Bissolati M; Cividini A; Nicosia A; Esumi M; Hayashi N; Mizuno K; Slobbe R; Oudshoorn P; Silini E; Asti M; Mondelli MU
J Med Virol; 1997 Jan; 51(1):1-5. PubMed ID: 8986942
[TBL] [Abstract][Full Text] [Related]
9. Expression and processing of hepatitis C virus structural proteins in Pichia pastoris yeast.
Martinez-Donato G; Acosta-Rivero N; Morales-Grillo J; Musacchio A; Vina A; Alvarez C; Figueroa N; Guerra I; Garcia J; Varas L; Muzio V; Dueñas-Carrera S
Biochem Biophys Res Commun; 2006 Apr; 342(2):625-31. PubMed ID: 16488393
[TBL] [Abstract][Full Text] [Related]
10. Serum antibodies against the hepatitis C virus E2 protein mediate antibody-dependent cellular cytotoxicity (ADCC).
Nattermann J; Schneiders AM; Leifeld L; Langhans B; Schulz M; Inchauspé G; Matz B; Brackmann HH; Houghton M; Sauerbruch T; Spengler U
J Hepatol; 2005 Apr; 42(4):499-504. PubMed ID: 15763336
[TBL] [Abstract][Full Text] [Related]
11. Delineation of regions important for heteromeric association of hepatitis C virus E1 and E2.
Yi M; Nakamoto Y; Kaneko S; Yamashita T; Murakami S
Virology; 1997 Apr; 231(1):119-29. PubMed ID: 9143310
[TBL] [Abstract][Full Text] [Related]
12. Chimeric hepatitis B virus/hepatitis C virus envelope proteins elicit broadly neutralizing antibodies and constitute a potential bivalent prophylactic vaccine.
Beaumont E; Patient R; Hourioux C; Dimier-Poisson I; Roingeard P
Hepatology; 2013 Apr; 57(4):1303-13. PubMed ID: 23150224
[TBL] [Abstract][Full Text] [Related]
13. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
Vietheer PT; Boo I; Drummer HE; Netter HJ
Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
[TBL] [Abstract][Full Text] [Related]
14. Humoral immune response to the E2 protein of hepatitis G virus is associated with long-term recovery from infection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors.
Tacke M; Schmolke S; Schlueter V; Sauleda S; Esteban JI; Tanaka E; Kiyosawa K; Alter HJ; Schmitt U; Hess G; Ofenloch-Haehnle B; Engel AM
Hepatology; 1997 Dec; 26(6):1626-33. PubMed ID: 9398008
[TBL] [Abstract][Full Text] [Related]
15. Characterization of hepatitis C virus structural proteins with a recombinant baculovirus expression system.
Hsu HH; Donets M; Greenberg HB; Feinstone SM
Hepatology; 1993 May; 17(5):763-71. PubMed ID: 8387945
[TBL] [Abstract][Full Text] [Related]
16. Expression and structural properties of a chimeric protein based on the ectodomains of E1 and E2 hepatitis C virus envelope glycoproteins.
Tello D; Rodríguez-Rodríguez M; Yélamos B; Gómez-Gutiérrez J; Ortega S; Pacheco B; Peterson DL; Gavilanes F
Protein Expr Purif; 2010 Jun; 71(2):123-31. PubMed ID: 20176110
[TBL] [Abstract][Full Text] [Related]
17. Antibodies directed to envelope proteins of hepatitis C virus outside of hypervariable region 1.
Lechner S; Rispeter K; Meisel H; Kraas W; Jung G; Roggendorf M; Zibert A
Virology; 1998 Apr; 243(2):313-21. PubMed ID: 9568031
[TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of human monoclonal antibodies against hepatitis C virus envelope glycoproteins.
da Silva Cardoso M; Siemoneit K; Sturm D; Krone C; Moradpour D; Kubanek B
J Med Virol; 1998 May; 55(1):28-34. PubMed ID: 9580883
[TBL] [Abstract][Full Text] [Related]
19. Signal sequences modulate the immunogenic performance of human hepatitis C virus E2 gene.
Sominskaya I; Alekseeva E; Skrastina D; Mokhonov V; Starodubova E; Jansons J; Levi M; Prilipov A; Kozlovska T; Smirnov V; Pumpens P; Isaguliants MG
Mol Immunol; 2006 May; 43(12):1941-52. PubMed ID: 16442623
[TBL] [Abstract][Full Text] [Related]
20. Cross-reactivity and clinical impact of the antibody response to hepatitis C virus second envelope glycoprotein (E2).
Hadlock KG; Gish R; Rowe J; Rajyaguru SS; Newsom M; Warford A; Foung SK
J Med Virol; 2001 Sep; 65(1):23-9. PubMed ID: 11505439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
